Mineralys Therapeutics SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 19, 2026, 4:37 p.m. ETView on SEC.gov
Departure/appointment of directors or officers · Financial statements and exhibits
AI summary, unreviewedMineralys Therapeutics Adds Two Independent Directors, Expanding Board From Seven to Nine
8-KAug. 11, 2026, 4:08 p.m. ETView on SEC.gov
Results of operations and financial condition · Departure/appointment of directors or officers · Financial statements and exhibits